Gene-editing technique could speed up study of cancer mutations
With the new method, scientists can explore many cancer mutations whose roles are unknown, helping them develop new drugs that target those mutations.
MIT faculty tackle big ideas in a symposium kicking off Inauguration Day
Ahead of the Institute’s presidential inauguration, panelists describe advances in their research and how these discoveries are being deployed to benefit the public.
The measuring tape heard round the world
Professor Emerita Nancy Hopkins and journalist Kate Zernike discuss the past, present, and future of women at MIT and beyond.
A simple paper test could offer early cancer diagnosis
The new diagnostic, which is based on analysis of urine samples, could also be designed to reveal whether a tumor has metastasized.
Two-component system could offer a new way to halt internal bleeding
The technology, which mimics the body’s natural clotting process, could help keep severely injured people alive until they are treated at a hospital.
Vaccine printer could help vaccines reach more people
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin.
Nanoparticles provoke immune response against tumors but avoid side effects
In a new study, immunostimulatory drugs slowed tumor growth without producing systemic inflammation.
Recycling plastics from research labs
With sustainability in mind, MIT’s EHS Lab Plastics Recycling Program gathers clean plastics from 212 MIT labs, recycling some 280 pounds per week.
Funding to Daniel Anderson’s lab will advance research on new delivery technology for RNA vaccines and therapies
The global health care company Sanofi is providing $25 million to advance RNA research.
New nanoparticles can perform gene editing in the lungs
Using these RNA-delivery particles, researchers hope to develop new treatments for cystic fibrosis and other lung diseases.
A novel combination therapy for treating vancomycin-resistant bacterial infections
Developed at SMART, the therapy stimulates the host immune system to more effectively clear bacterial infections and accelerate infected wound healing.
STEAM power on the runway
Boston teen designers create fashion inspired by award-winning images from MIT laboratories.
Why lung cancer doesn’t respond well to immunotherapy
A new study reveals that lymph nodes near the lungs create an environment that weakens T-cell responses to tumors.
Targeting cancer with a multidrug nanoparticle
Using bottlebrush-shaped particles, researchers can identify and deliver synergistic combinations of cancer drugs.
MIT researchers develop an AI model that can detect future lung cancer risk
Deep-learning model takes a personalized approach to assessing each patient’s risk of lung cancer based on CT scans.